OptiBiotix Health gets key validation for probiotic product

Writer,

OptiBiotix Health said subsidiary ProBiotix Health had completed process validation under pharmaceutical good manufacturing practices for its probiotic product as a drug substance.

The company had also received a letter from the US Food and Drug Administration affirming the product's generally recognized as safe status.

'Few marketed probiotics have achieved this level of proven safety and efficacy and it has triggered another milestone payment in the US pharmaceutical agreement we announced last year,' chief executive Steve Prescott said.


Related content

OptiBiotix to jointly research affect of products on sleep, anxiety

Dietary supplements group OptiBiotix Health said it had agreed to jointly fund and carry out a research project examining the role of its microbiome products...

Mon, 11/01/2021 - 09:51


OptiBiotix Health inks licencing agreement with Genuine Health

Dietary supplements group OptiBiotix Health said subsidiary ProBiotix Health had granted a non-exclusive license to Genuine Health for a cardiovascular health product in Canada and...

Wed, 18/11/2020 - 07:53


OptiBiotix launches weight management products in Australia, New Zealand

Dietary supplements company OptiBiotix Health said it had launched meal replacement shakes and bars containing its weight management technology in Australia and New Zealand with...

Mon, 12/10/2020 - 08:55


OptiBiotix Health enters Singapore distribution pact with United Italian

Dietary supplements group OptiBiotix Health said subsidiary ProBiotix Health had entered into an exclusive distribution agreement with United Italian Trading Corporation.

The deal would see...

Tue, 06/10/2020 - 09:08


OptiBiotix Health partner Seed Health gets FDA not for probiotic trial

Dietary supplements group OptiBiotix Health welcomed news that partner Seed Health had received authorisation in the US for an investigational new drug application.

Authorisation from...

Fri, 02/10/2020 - 07:33